Insider · CIK 0001031847

MILLER RICHARD A MD

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001031847

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-18	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$12.05	+$60.3K	1,193,103
2026-05-18	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+1,932 sh	$12.01	+$23.2K	1,195,035
2025-12-04	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1M sh	—	—	1,000,000
2025-05-07	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+559K sh	$3.50	+$1.96M	1,136,707
2025-05-07	CRVSCorvus Pharmaceuticals, Inc. · Warrant (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−559K sh	—	—	0
2024-12-20	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+750K sh	—	—	750,000
2024-05-10	CRVSCorvus Pharmaceuticals, Inc.G Gift	Director, President and CEO	GGift	−302K sh	—	—	1,188,103
2024-05-06	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+578K sh	$1.73	+$1M	577,634
2024-05-06	CRVSCorvus Pharmaceuticals, Inc. · Warrant (Right to Buy)P Purchase	Director, President and CEO	PPurchase	+559K sh	—	—	559,073
2023-12-06	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+500K sh	—	—	500,000
2023-06-12	BOLTBolt Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-03-31	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+800K sh	—	—	800,000
2022-12-14	BOLTBolt Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-12-14	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+10K sh	$0.78	+$7,812	1,490,119
2022-12-13	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+50K sh	$0.74	+$37K	1,480,119
2022-09-28	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+25K sh	$0.76	+$19.1K	1,394,405
2022-09-20	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+12.3K sh	$0.81	+$9,964.23	1,361,705
2022-09-20	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+2,700 sh	$0.82	+$2,214	1,364,405
2022-09-20	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$0.81	+$4,075	1,369,405
2022-08-11	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+320K sh	—	—	320,000
2022-06-27	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$1.00	+$4,984.5	1,349,405
2022-06-24	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$1.03	+$5,150	1,344,405
2022-06-10	BOLTBolt Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-06-06	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+890 sh	$1.01	+$898.9	1,339,405
2022-06-02	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+4,830 sh	$0.98	+$4,733.4	1,338,345
2022-06-02	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+170 sh	$0.97	+$164.9	1,338,515
2022-03-31	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+15K sh	$1.64	+$24.5K	1,333,515
2022-03-24	BOLTBolt Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-03-17	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$1.59	+$7,950	1,318,515
2022-03-15	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+25K sh	$1.47	+$36.7K	1,313,515
2021-09-09	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+320K sh	—	—	320,000
2021-08-20	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+10K sh	$1.93	+$19.3K	1,288,515
2021-05-04	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+35.7K sh	$2.80	+$100K	35,714
2021-02-17	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+100K sh	$3.50	+$350K	1,278,515
2020-12-16	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+320K sh	—	—	320,000
2019-12-12	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+320K sh	—	—	320,000
2019-11-13	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+14.7K sh	$3.00	+$44.2K	1,178,515
2019-11-12	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+272 sh	$2.90	+$788.8	1,163,779
2019-08-07	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+2,500 sh	$3.54	+$8,850	1,163,507
2019-08-06	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$3.58	+$17.9K	1,161,007
2019-06-14	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+11.7K sh	$3.40	+$39.7K	1,156,007
2019-06-13	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+343 sh	$3.52	+$1,207.36	1,144,350
2019-06-11	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+6,000 sh	$3.67	+$22K	1,144,007
2019-06-07	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+9,212 sh	$3.37	+$31K	1,138,007
2018-12-27	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+20K sh	$3.29	+$65.9K	1,128,795
2018-12-20	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$4.40	+$22K	1,103,795
2018-12-20	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$4.39	+$22K	1,108,795
2018-12-12	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+250K sh	—	—	250,000
2018-12-11	CRVSCorvus Pharmaceuticals, Inc.G Gift	Director, President and CEO	GGift	−10K sh	—	—	1,108,795
2018-12-11	CRVSCorvus Pharmaceuticals, Inc.G Gift	Director, President and CEO	GGift	−10K sh	—	—	1,098,795

Recent filings

Accepted (ET)
May 204
MILLER RICHARD A MD0001610717-26-000160
SEC(opens sec.gov)
Dec 84
MILLER RICHARD A MD0001610717-25-000411
SEC(opens sec.gov)
May 94
MILLER RICHARD A MD0001610717-25-000115
SEC(opens sec.gov)
Dec 234
MILLER RICHARD A MD0001610717-24-000550
SEC(opens sec.gov)
May 144
MILLER RICHARD A MD0001610717-24-000237
SEC(opens sec.gov)
May 74
MILLER RICHARD A MD0001610717-24-000231
SEC(opens sec.gov)
Dec 84
MILLER RICHARD A MD0001610717-23-000395
SEC(opens sec.gov)
Jun 144
MILLER RICHARD A MD0001209191-23-037111
SEC(opens sec.gov)
Apr 34
MILLER RICHARD A MD0001140361-23-015800
SEC(opens sec.gov)
Dec 164
MILLER RICHARD A MD0001209191-22-061591
SEC(opens sec.gov)
Dec 154
MILLER RICHARD A MD0001567619-22-021650
SEC(opens sec.gov)
Sep 284
MILLER RICHARD A MD0001567619-22-017917
SEC(opens sec.gov)
Sep 204
MILLER RICHARD A MD0001567619-22-017639
SEC(opens sec.gov)
Aug 154
MILLER RICHARD A MD0001567619-22-016298
SEC(opens sec.gov)

Companies

Address

C/O CORVUS PHARMACEUTICALS, INC. 901 GATEWAY BOULEVARD, THIRD FLOOR

SOUTH SAN FRANCISCO, CA, 94080